A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration

Completed · Phase 1

Conditions studied: Healthy Volunteer

In brief

The purpose of this study is to evaluate mass balance, pharmacokinetics and safety of \[14C\] ABBV-552 in healthy, male volunteers following administration of a single oral dose.

Key facts

Study ID

NCT06278766

Run by

AbbVie

People needed

8

Starts

2024-02-21

Expected to finish

2024-04-19

Last updated by the study team

2024-04-29

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male volunteers in general good health at Screening.

You may not qualify if…

• Considering fathering a child or donating sperm during the study and for 100 days after study drug administration.

Where it is running

• Fortrea Clinical Research Unit Inc /ID# 262684 — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.